Published in Women's Health Weekly, January 15th, 2004
The recommendation came following a joint meeting of the FDA's Nonprescription Drugs and Reproductive Health Drugs Advisory Committees. The FDA will now consider the recommendation. In presentations to the committees, Barr and WCC, among others, stated that increased education about the availability of the Plan B emergency contraceptive, and lowering of barriers that delay access,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly